Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation

Although the oral administration of Bifidobacterium longum (B. longum) relieves the signs of irritable bowel syndrome (IBS) in clinical settings, the mechanisms underlying its effects are unclear. In this study, we evaluated the precise effects of B. longum on IBS via regulation of Paneth cell funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chunhua, Fang, Xue, Xu, Jiajia, Gao, Jun, Zhang, Ling, Zhao, Jiulong, Meng, Yuting, Zhou, Wei, Han, Xu, Bai, Yu, Li, Zhaoshen, Zou, Duowu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524277/
https://www.ncbi.nlm.nih.gov/pubmed/32584650
http://dx.doi.org/10.1080/19490976.2020.1782156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524277/
https://www.ncbi.nlm.nih.gov/pubmed/32584650
http://dx.doi.org/10.1080/19490976.2020.1782156

Ejemplares similares